$CATB News Article - Catabasis Pharmaceuticals to Present the MoveDMD Trial of Edasalonexent in Duchenne Muscular Dystrophy at the 24th International Congress of the World Muscle Society https://marketwirenews.com/news-releases/cata...34853.html
(0)
(0)
Astria Therapeutics, Inc. (ATXS) Stock Research Links